Suppr超能文献

SV40 转化的人细胞在裸鼠体内形成肿瘤:SV40 T 抗原的作用。

Tumor formation by SV40-transformed human cells in nude mice: the role of SV40 T antigens.

作者信息

Choi K H, Tevethia S S, Shin S

出版信息

Cytogenet Cell Genet. 1983;36(4):633-40. doi: 10.1159/000131987.

Abstract

Human cells transformed in vitro by SV40 rarely form tumors in nude mice. We examined whether these cells as a group are inherently nontumorigenic or whether they are potentially tumorigenic but rejected by the athymic host, possibly by nonspecific immune mechanisms. SV80 and NG8 are SV40-transformed human cell lines that express all of the transformed properties, including anchorage-independent growth, but do not form tumors in adult nude mice after injection of as many as 10(8) cells. Both the SV80 and NG8 cell lines have SV40-specific transplantation antigens which crossreact with those present on SV40-transformed (but tumorigenic) rodent cells. We found that SV80 cells, though not NG8 cells, induced progressively growing lethal tumors if the cells are injected repeatedly into neonatal nude mice. Somatic cell hybrids between SV80 or NG8 cells and a highly tumorigenic cell line derived from a human tumor continue to express the virus-induced antigens and fail to form tumors in adult nude mice. These results strongly suggest that at least for some SV40-transformed human cells, the failure to form tumors in nude mice may be due to their expression of virus-induced transplantation antigens rather than the absence of tumorigenic potential.

摘要

经SV40体外转化的人类细胞在裸鼠中很少形成肿瘤。我们研究了这些细胞作为一个群体是天生就无致瘤性,还是它们具有潜在致瘤性但被无胸腺宿主排斥,可能是通过非特异性免疫机制。SV80和NG8是SV40转化的人类细胞系,它们表达所有转化特性,包括不依赖贴壁生长,但在注射多达10⁸个细胞后,在成年裸鼠中不形成肿瘤。SV80和NG8细胞系都有SV40特异性移植抗原,这些抗原与SV40转化的(但具有致瘤性的)啮齿动物细胞上的抗原有交叉反应。我们发现,如果将SV80细胞反复注射到新生裸鼠中,它们会诱导出逐渐生长的致命肿瘤,而NG8细胞则不会。SV80或NG8细胞与源自人类肿瘤的高致瘤性细胞系之间的体细胞杂种继续表达病毒诱导的抗原,并且在成年裸鼠中不形成肿瘤。这些结果强烈表明,至少对于一些SV40转化的人类细胞来说,在裸鼠中不能形成肿瘤可能是由于它们表达了病毒诱导的移植抗原,而不是缺乏致瘤潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验